WHO updates guidelines on opioid dependence treatment and overdose prevention
Oscar Reyes
6 Apr 2026
Oscar Reyes
6 Apr 2026
FDA Approves First New Molecular Entity Under National Priority Voucher Program
http://www.fda.gov/news-events/press-announcements/fda-approves-first-new-molecular-entity-under-national-priority-voucher-program
Cristina Mitchell
27 Mar 2026
FDA Approves First Gene Therapy for Severe Leukocyte Adhesion Deficiency Type I
http://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapy-severe-leukocyte-adhesion-deficiency-type-i
Oscar Reyes
26 Mar 2026
FDA Approves Drug to Treat Neurologic Manifestations of Hunter Syndrome
http://www.fda.gov/news-events/press-announcements/fda-approves-drug-treat-neurologic-manifestations-hunter-syndrome